摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

十二酸己酯 | 34316-64-8

中文名称
十二酸己酯
中文别名
月桂酸己酯
英文名称
lauric acid hexyl ester
英文别名
hexyl dodecanoate;n-hexyl laurate;hexyl laurate;Laurinsaeure-hexylester;Dodecansaeure-hexylester
十二酸己酯化学式
CAS
34316-64-8
化学式
C18H36O2
mdl
——
分子量
284.483
InChiKey
CMBYOWLFQAFZCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    -3.4 °C
  • 沸点:
    130 °C
  • 密度:
    0.864±0.06 g/cm3(Predicted)
  • LogP:
    7.918 (est)
  • 物理描述:
    Liquid
  • 保留指数:
    1963

计算性质

  • 辛醇/水分配系数(LogP):
    7.6
  • 重原子数:
    20
  • 可旋转键数:
    16
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2915900090
  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    2-8°C

SDS

SDS:a759c83812d0034182aee97a3a6f5ccc
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Pharmaceutical composition for transdermal administration
    摘要:
    本发明涉及一种用于经皮给药的药物组合物,其特征在于它包括:a)可选的聚合物释放基质,能够在干燥后形成柔性薄膜,选择自纤维素聚合物或共聚物或乙烯基吡咯烷酮/醋酸乙烯酯共聚物;b)活性成分;c)促进活性成分经皮吸收的促进剂;d)生理上可接受的非水溶剂,能够溶解释放基质、活性成分和经皮吸收促进剂,并且在接触皮肤时能够通过蒸发迅速去除。
    公开号:
    US06010716A1
  • 作为产物:
    描述:
    月桂酸乙烯酯正己醇二氧化碳 作用下, 46.02 ℃ 、8.81 MPa 条件下, 反应 3.5h, 以97%的产率得到十二酸己酯
    参考文献:
    名称:
    Immobilization of lipase on biocompatible co-polymer of polyvinyl alcohol and chitosan for synthesis of laurate compounds in supercritical carbon dioxide using response surface methodology
    摘要:
    Biocompatible co-polymer matrix has great importance for enzyme immobilization and subsequent bio-catalytic applications to synthesize important organic moieties. Citronellyl laurate is a fatty-acid-ester having pleasant fruity aroma and widely used as/in emulsifier, lubricant in textile, paint or ink-additives, surfactants, perfumery and food-flavouring ingredient. In present study, Burkholderia cepacia lipase (BCL) was immobilized on biodegradable co-polymer of chitosan (CHI) and polyvinyl alcohol (PVA). The synthesized bio-catalyst {PVA:CHI:BCL (6:4:2.5)} was characterized by SEM, TGA, lipase assay and protein-content analysis. This biocatalyst was applied to synthesize citronellyl laurate in supercritical carbon-dioxide (SC-CO2) using response surface methodology with five-factor-three-level Box-Behnken-design to optimize reaction parameters (citronellol: 8.5 mmol; vinyl laurate: 19.87 mmol; biocatalyst: 175.6 mg; temperature: 46.02 degrees C; pressure: 8.81 MPa) which provided 94 +/- 1.52% yield. The protocol is extended to synthesize various important 12 laurate compounds with excellent yield (90-98%) and noteworthy recyclability (upto studied 5 recycles). Interestingly, immobilized PVA/CHI/lipase biocatalyst showed 4-fold higher bio-catalytic activity than free lipase in SC-CO2. Moreover, the biocatalyst activity assessment study showed remarkable activity-stability of immobilized biocatalyst in SC-CO2 media as compared to free enzyme. Thus, present protocol demonstrated potential biocatalytic applications for synthesis of important laurate compounds with excellent recyclability in SC-CO2 as greener biocatalyst and reaction medium. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.procbio.2015.04.019
点击查看最新优质反应信息

文献信息

  • PHOTOPROTECTIVE COMPOSITIONS COMPRISING PHOTOSENSITIVE 1,3,5-TRIAZINE COMPOUNDS, DIBENZOYLMETHANE COMPOUNDS AND SILICEOUS S-TRIAZINES SUBSTITUTED WITH TWO AMINOBENZOATE OR AMINOBENZAMIDE GROUPS
    申请人:L'OREAL
    公开号:US20170135933A1
    公开(公告)日:2017-05-18
    UV-photoprotective, topically applicable cosmetic/dermatological compositions contain: (a) at least one dibenzoylmethane compound, (b) at least one 1,3,5-triazine compound that is photosensitive in the presence of a dibenzoylmethane compound, and (c) at least one siliceous s-triazine compound substituted with two aminobenzoate or aminobenzamide groups, or a tautomeric form thereof, the 1,3,5-triazine compounds being improvedly photostable in such compositions.
    UV-光保护,可局部应用的化妆品/皮肤科组合物包含: (a) 至少一种二苯甲酮化合物, (b) 至少一种1,3,5-三嗪化合物,在二苯甲酮化合物存在时对光敏感,以及 (c) 至少一种含有两个氨基苯甲酸酯或氨基苯酰胺基团的硅质s-三嗪化合物,或其互变异构体,这些1,3,5-三嗪化合物在这种组合物中具有改进的光稳定性。
  • [EN] ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS<br/>[FR] COMPOSÉS ISOXAZOLINE ET LEUR UTILISATION EN TANT QU'AGENTS DE LUTTE CONTRE LES ORGANISMES NUISIBLES
    申请人:PI INDUSTRIES LTD
    公开号:WO2021038501A1
    公开(公告)日:2021-03-04
    The present invention discloses an isoxazoline compound of formula (I), wherein, R1, R2a, R2b, R2c, A, T and Z are as defined in the detailed description. The present invention further discloses methods for preparation of compounds of formula (I) and use of the compounds of formula (I) as a pest control agents.
    本发明公开了一种式(I)的异氧杂环烷化合物,其中,R1、R2a、R2b、R2c、A、T和Z如详细说明中所定义。本发明还公开了制备式(I)化合物的方法以及将式(I)化合物用作杀虫剂的用途。
  • BORON-CONTAINING SMALL MOLECULES
    申请人:Xia Yi
    公开号:US20100256092A1
    公开(公告)日:2010-10-07
    This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.
    这项发明涉及6-取代苯硼酯化合物等物品,以及它们用于治疗细菌感染的用途。
  • Kappa agonist compounds and pharmaceutical formulations thereof
    申请人:——
    公开号:US20030144272A1
    公开(公告)日:2003-07-31
    Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics are provided. The compounds of formulae I, II, IIA, III, IIIA, IIIB, IIIB-i, IV and IVA have the structure: 1 2 wherein R 1 , R 2 , R 3 , R 4 ; and X, X 4 , X 5 , X 7 , X 9 ; Y, Z and n are as described in the specification.
    提供具有kappa阿片受体激动剂活性的化合物,含有这些化合物的组合物以及使用它们作为镇痛剂的方法。 具有以下结构的化合物I、II、IIA、III、IIIA、IIIB、IIIB-i、IV和IVA: 1 2 其中 R 1 ,R 2 ,R 3 ,R 4 ;和 X,X 4 ,X 5 ,X 7 ,X 9 ; Y,Z和n如规范中所述。
  • CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES
    申请人:Nissan Chemical Industries, Ltd.
    公开号:US20180022760A1
    公开(公告)日:2018-01-25
    To provide novel pesticides, especially insecticides or acaricides. A condensed heterocyclic compound represented by the formula (1) or its salt or an N-oxide thereof: wherein D substituted with —S(O) n R 1 is a ring represented by any one of D1, D2 and D3, Q is a ring represented by any one of Q1, Q2, Q3 and Q4, R 1 is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, (C 1 -C 6 ) alkyl optionally substituted with R 1a , C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 3 -C 6 cycloalkyl (C 1 -C 6 ) alkyl, C 3 -C 6 halocycloalkyl (C 1 -C 6 ) alkyl or hydroxy (C 1 -C 6 ) alkyl, R 1a is C 1 -C 8 alkoxycarbonyl, and n is an integer of 0, 1 or 2.
    提供新型杀虫剂,特别是杀虫剂或杀螨剂。由式(1)表示的缩合杂环化合物或其盐或其N-氧化物: 其中D被—S(O)nR1取代,是由D1、D2和D3中的任何一个表示的环,Q是由Q1、Q2、Q3和Q4中的任何一个表示的环,R1是C1-C6烷基,C1-C6卤代烷基,(C1-C6)烷基,可选地取代R1a,C2-C6烯基,C2-C6卤代烯基,C2-C6炔基,C2-C6卤代炔基,C3-C6环烷基,C3-C6卤代环烷基,C3-C6环烷基(C1-C6)烷基,C3-C6卤代环烷基(C1-C6)烷基或羟基(C1-C6)烷基,R1a是C1-C8烷氧羰基,n是0、1或2的整数。
查看更多